2C-I Facts
Psychedelic;
Description
2C-I (2,5-dimethoxy-4-iodophenethylamine) is a synthetic psychedelic of the phenethylamine class. It activates serotonin receptors in the brain, producing the visual distortions and perceptual shifts characteristic of classical psychedelics.[1]
Subjective effects include geometric visual patterns, brightened colors, tactile enhancement, mood elevation, and a persistent physical energy.[2] The experience carries a distinct stimulant character — more physically energizing than tryptamine psychedelics, with vivid colors and a social warmth that places it between 2C-B and mescaline.
2C-I does not produce physical dependence,[3] and rapid tolerance limits repeated use;[4] the primary risk is cardiovascular — high blood pressure and vasoconstriction can trigger serious events in predisposed individuals.[5] Combining it with antidepressants or MAOIs dramatically amplifies effects and risks a life-threatening serotonin response.
Dose and durationby route · individual sensitivity varies
Starts in 15 – 45 minLasts 6 – 10 hoursAfter-effects 2 – 8 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Negligible
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 8.5 days
- Carries over to
- LSD;
psilocybin; mescaline; 2C-B; 2C-E; DOI; DMT
Effectslikely at a common dose
- Perception
- Color enhancement;
Color alteration; Environmental patterning; Music enhancement; Tracers; Visual drifting; Brightness alteration; Geometry; Visual breathing; +29 possible, including Visual haze / noise, Spatial disorientation, Vestibular distortion - Body
- Stimulation;
Pupil dilation; Wakefulness; Body scan awareness; +31 possible, including Muscle tension, Heart rate perception changes, Insomnia - Thinking
- Aesthetic enhancement;
+35 possible, including Cognitive impairment, Suggestibility enhancement, Memory suppression - Feeling
- Emotional enhancement;
+8 possible, including Emotional lability, Anxiety, Dysphoria - Self
- none likely · 10 possible, including Derealization, Depersonalization, Communication suppression
- Time
- Time alteration;
+3 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 5 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Halberstadt AL, Geyer MA (2014) Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response — Neuropharmacology doi:10.1016/j.neuropharm.2013.08.025
- [2]
- [3]^Gil-Martins E, Barbosa DJ, Borges F, Remiao F, Silva R (2025) Toxicodynamic insights of 2C and NBOMe drugs - Is there abuse potential? — Toxicology Reports doi:10.1016/j.toxrep.2025.101890
- [4]^Wallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, et al. (2023) Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential — Nature Communications doi:10.1038/s41467-023-44016-1
- [5]^Drees JC, Stone JA, Wu AH (2009) Morbidity involving the hallucinogenic designer amines MDA and 2C-I — Journal of Forensic Sciences doi:10.1111/j.1556-4029.2009.01199.x